Sulfonylureas
Kobayashi, K.; Shimano, H.
Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 3): 602-607
2012
ISSN/ISBN: 0047-1852 PMID: 22768585 Document Number: 661797
Document emailed within 1 workday
Related Documents
Frey, H. 1971: No sulfonylureas to pregnant diabetics Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 91(32): 2337Stahl, M.; Berger, W. 1995: Sulfonylureas: pharmacology and hypoglycemic risk Journees Annuelles de Diabetologie de l'Hotel-Dieu 1995: 107-119
Sartor, G.; Melander, A.; Scherstén, B.; Wåhlin-Boll, E. 1980: Kinetics-effect relations of glipizide and other sulfonylureas Acta Endocrinologica. Supplementum 239: 3-5
Wascher, T.C. 1998: Sulfonylureas and cardiovascular mortality in diabetes: a class effect? Circulation 97(14): 1427-1428
Kirk, J.K.; Pearce, K.A.; Michielutte, R.; Summerson, J.H. 1999: Troglitazone or metformin in combination with sulfonylureas for patients with type 2 diabetes? Journal of Family Practice 48(11): 879-882
Denooz, R.; Charlier, C. 2010: Sulfonylureas dosage: from therapeutic monitoring to differential diagnosis of hyperinsulinism Revue Medicale de Liege 65(9): 493-497
Romley, J.A.; Gong, C.; Jena, A.B.; Goldman, D.P.; Williams, B.; Peters, A. 2015: Association between use of warfarin with common sulfonylureas and serious hypoglycemic events: retrospective cohort analysis Bmj 351: H6223
Deleers, M.; Lebrun, P.; Malaisse, W.J. 1984: Effects of cations, ionophores and hypoglycemic sulfonylureas on the fluorescence of fluorescein-labelled pancreatic islets Research Communications in Chemical Pathology and Pharmacology 44(1): 83-92
Deleers, M.; Grognet, P.; Mahy, M.; Brasseur, R.; Malaisse, W.J. 1983: Synergistic effect of hypoglycemic sulfonylureas and negative phospholipids on calcium transport: ionic and conformational aspects Research Communications in Chemical Pathology and Pharmacology 41(3): 407-424
Garcia Viveros, M.; Prado Vega, R.; Rull, J.A.; Lozano-Castañeda, O. 1971: Chlorpropamide-metformin in obese diabetics or diabetics with side effects from sulfonylureas. 2-year results La Prensa Medica Mexicana 36(7): 347-349